Profile
VeriLuce Therapeutics is an R&D/early-stage drug development company currently developing novel small molecules targeting concomitantly two chemokine receptors in dual antagonistic mode. The objective is to target such receptors within the tumour microenvironment to modulate the immune system to activate tumour-killing immune cells and suppress tumour-enhancing immune cells. Potential target indications for treatment include Triple Negative Breast cancer and Hepatocellular Carcinoma.
Website
verilucetherapeutics.comContact
-
Elena Frigerio, Founder and Chief Executive OfficerTel: +1 647-965-1963
-
-
-
-
-
Event details
Date: September 25 - 27, 2024
Event contact
Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
13 in total
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for… -
CanaQuest is a clinical-stage life sciences company developing innovative cannabinoid-based therapeutics. Its… -
Canurta stands at the forefront of biotechnological innovation, developing new small-molecule therapeutics from… -
Healthyher.Life is a women’s health navigator platform for its member community of women and gender-diverse… -
Hole Medical Ltd. is a pioneering digital health aggregator at the forefront of healthcare innovation. Its… -
ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel bioconjugate therapeutics… -
For over two decades, Inertia has been the trusted partner for start-ups in the medical device, diagnostic, and… -
JN Nova Pharma is a Canadian biotech company collaborating with the National Research Council of… -
Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead… -
PurMinds is a neuro-medicine company pursuing breakthrough solutions to neurological disorders by leveraging… -
QurCan Therapeutics is a biotechnology company that has developed the next-generation nanoparticle for safer and… -
VeriLuce Therapeutics is an R&D/early-stage drug development company currently developing novel small…